Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group

Sponsor
Deraya University (Other)
Overall Status
Completed
CT.gov ID
NCT06070571
Collaborator
(none)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

A double-blind, prospective, randomized, intra-individual comparative, single-center clinical study was conducted. Participants were placed in parallel groups, and the study was performed in the Department of Operative Dentistry and Periodontology, Dental School and Hospital, Minia university to compare the antibacterial activity of yarrow Moringa herbal combinations nanoparticles in compared to Chlorhexidine as a potential treatment for gingivitis.

Condition or Disease Intervention/Treatment Phase
  • Drug: Yarrow and moringa mixture
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Clinical Assessment of Antibacterial Anti-inflammatory Activities of Yarrow Moringa Herbal Combinations in Bucco Adhesive Films
Actual Study Start Date :
May 20, 2022
Actual Primary Completion Date :
Dec 20, 2022
Actual Study Completion Date :
May 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Bucco-adhesive films with Yarrow and Moringa extract nanoparticles

Drug: Yarrow and moringa mixture
yarrow and moringa mixture nano particles loaded on buccal film

Active Comparator: control group

Cholorohexiden oral gargles

Drug: Yarrow and moringa mixture
yarrow and moringa mixture nano particles loaded on buccal film

Outcome Measures

Primary Outcome Measures

  1. antibacterial and anti inflammatory activities [two weeks]

    scoring of erthymia and pain (no pain=0) and the other end (worst pain=10).

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • a minimum of four natural uncrowned teeth in one quadrant present

  • good general health

  • can follow instructions

Exclusion Criteria:
  • were pregnant or breastfeeding

  • evidence of antibiotic use during the 4 weeks prior to the study

  • were allergic to personal care/consumer products or their ingredients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Soad A. Mohamad Minya المنيا Egypt 05673

Sponsors and Collaborators

  • Deraya University

Investigators

  • Study Director: soad ali, PhD, faculty of pharmacy, Deraya university

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deraya University
ClinicalTrials.gov Identifier:
NCT06070571
Other Study ID Numbers:
  • 3/23
First Posted:
Oct 6, 2023
Last Update Posted:
Oct 6, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2023